ePlus (PLUS) director awarded 1,478 restricted shares; now 5,772
ePlus Inc. (PLUS) reported a Form 4 for Director Renee Bergeron.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ePlus Inc. (PLUS) reported a Form 4 for Director Renee Bergeron. On 10/01/2025, she acquired 1,478 shares of common stock at $0 as a restricted stock award, increasing her directly held shares to 5,772.
The award was granted under the Company’s 2024 Non-Employee Director Long Term Incentive Plan and is subject to a Restriction Period ending on the first anniversary of the grant. Under certain circumstances described in the plan, restrictions may lapse or the shares may be forfeited and transferred back to the Company.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,478 | $0.00 | $0.00 |
Footnotes (1)
- F1. This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant (the "Restriction Period"). As more fully described in the Plan, under certain other circumstances the restrictions may lapse, or the shares may be forfeited and transferred back to the Company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ePlus (PLUS) disclose in this Form 4?
What type of award was granted to the ePlus (PLUS) director?
What is the reporting person’s relationship to ePlus (PLUS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.